Written for Veeva Systems
Patients rely on CSL Behring therapies for their quality of life and, in many cases, for life itself. The company specializes in researching, developing, manufacturing and marketing biotherapies to treat serious and rare medical conditions. CSL Behring makes 41 products in Switzerland, Germany, Australia, and the U.S. Unlike conventional pharmaceuticals, biotherapies are derived from human blood plasma or made using recombinant technologies.
A few years ago, the CSL Behring operations group realized that, to bring life-saving treatments to market faster, with fewer errors and better compliance, it needed an electronic trial master file (eTMF) system to replace paper-based processes.
Thought Leadership Paper
Written for Temenos
The most successful banks in today’s marketplace take a specific approach to their business, consistently striving to provide experience-driven banking. They focus not only on conducting financial transactions, but also on providing products and services that improve a customer’s life and support their goals. They move from being simply transaction providers to trusted advisors.
But the ever-changing customer ecosystem makes delivering that service a daunting challenge. Customers want to consume services where, when and how they want them—usually on their mobile device of choice—and they expect online banking offerings to be completely personalized, to be available through non-traditional sources, and to include suggestions for new products that might be of interest.
Written for Fran DiNuzzo, President and CEO, ILC Dover
As we developed our corporate rebranding, we didn’t focus solely on eye-catching colors or trendy designs. We wanted every element of our new brand to be a clear, direct reflection of the ILC Dover story and our people.
Our new website greets visitors with a brief video that conveys our new brand and highlights our creative, energetic employees who always seek innovation to achieve what was never before possible.
This approach to our work has remained unchanged since we started providing engineered solutions to customer problems back in 1947.
Written for Rita Numerof, PhD, President, Numerof & Associates
In a steady stream of news stories, health systems put quality care and positive patient outcomes on the back burner as they try to haul in as much money as they can.
Denying coverage for mental health issues and burdening patients with surprise medical bills make it seem that providers are asking, “How many ways can we say no?” This is common in the current payment environment, and it must stop.
With the current model, too many providers do only what they get paid to do, and no more. Providing the highest quality care—no matter the cost—isn’t anywhere near top of mind.
Written for Stewart H. Rosen, MD, Vice President, Medical Affairs, Quintiles
Life sciences companies sometimes lose sight of patients while they focus on research for breakthrough drugs. Slow-moving clinical trials prevent timely access to life-saving medications, which can hinder patients’ chances for longer, better lives and maybe even survival.
Sluggish trials make it difficult for companies to prosper as well—they can lose as much as $8 million each day a drug is delayed from reaching the market.
About 1.7 million patients participate in 80,000 drug company-sponsored trials worldwide each year, and though companies spend an average of $300,000 to recruit each participant for a phase 3 clinical trial, nearly half of trial sites (48%) are unable to enroll enough patients.
Written for Patty Stoll, ILC Dover
Space Systems | Manager and Team Leader | Resourceful, Results-Oriented Problem Solver
My time in the Marine Corps and at Lockheed Martin helped me develop the tools I needed for my first role at ILC Dover as Project Engineer. In my 13 years with ILC, I’ve worked in the Flight Engineering Group, managed the company’s space suit and space products programs, and I’m currently Division Manager of Space Systems.
Written for Alexion Pharmaceuticals
Executive Role Description: US Diagnostics Lead (DIAG)
Overview of US Diagnostics Lead
The main responsibility of the US Diagnostics Lead is to develop and manage US diagnostic initiatives that lead to faster diagnosis and improved patient outcomes across our treated or anticipated disease states. Also, this role coordinates with internal and external stakeholders to implement best practices for diagnosis.
Employee Newsletter Article
Written for Campbell Soup
It can make a shopper miserable. Trying to find their favorite Campbell’s soup on supermarket shelves that have been picked over, depleted and disorganized. Today’s busy shopper, pressed for time, will just as soon walk away than continue the frustrating search.
“One of the biggest challenges we face with consumers is the difficulty they have finding our products,” says Keith Olscamp – Vice President Retail and Broker Sales Operations. “If you stand in front of the condensed soup section, there are a lot of items with different designations for flavor and variety, and to consumers it’s very confusing. Our research has shown that when most shoppers go into the store and can’t find what they’re looking for right away, they just move on.”
Employee Training Module
Written for Project Management Institute
The Control Schedule Process
You’re driving your car and hurrying to get to an important appointment. There are no delays, only green lights, and you’re optimistic you’ll be there on time. Then you see a large orange sign—Detour. Unsettled and a little angry, you veer onto an alternate route and your chances of being on time are gone.
That kind of sudden change can happen to your project schedule as well, making you take an “alternate route” that causes you to miss important deadlines. That can be unnerving, but hold on—there’s hope.